Effects of the Natural Peptide Crotamine from a South American Rattlesnake on Candida auris, an Emergent Multidrug Antifungal Resistant Human Pathogen
Year: 2019
Type: article
Abstract: Invasive Candida infections are an important growing medical concern and treatment options are limited to a few antifungal drug classes, with limited efficacies depending on the infecting organism. In this scenario, invasive infections caused by multiresistant Candida auris are emerging in several places around the world as important healthcare-associated infections. As antimicrobial peptides (AMPs) exert their activities primarily through mechanisms involving membrane disruption, they have a lower chance of inducing drug resistance than general chemical antimicrobials. Interestingly, we previously described the potent candicidal effect of a rattlesnake AMP, crotamine, against standard and treatment-resistant clinical isolates, with no hemolytic activity. We evaluated the antifungal susceptibility of several Candida spp. strains cultured from different patients by using the Clinical and Laboratory Standards Institute (CLSI) microdilution assay, and the antifungal activity of native crotamine was evaluated by a microbial growth inhibition microdilution assay. Although all Candida isolates evaluated here showed resistance to amphotericin B and fluconazole, crotamine (40–80 µM) exhibited in vitro activity against most isolates tested. We suggest that this native polypeptide from the South American rattlesnake Crotalus durissus terrificus has potential as a structural model for the generation of a new class of antimicrobial compounds with the power to fight against multiresistant Candida spp.
Source: Biomolecules
DOI: 10.3390/biom9060205
Authors: Caroline Dal Mas(Formal analysis, Methodology, Writing – original draft, Writing – review & editing), Luana Rossato(Formal analysis, Methodology, Writing – original draft, Writing – review & editing), Thaís Shimizu(Formal analysis), Eduardo B. Oliveira(Supervision, Writing – review & editing), Pedro I. da Silva Junior(Methodology, Writing – original draft, Writing – review & editing), Jacques F. Meis(Writing – review & editing), Arnaldo Lopes Colombo(Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing), Mirian A. F. Hayashi(Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Resources)
Language: English
Subfield: Microbiology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,216
Awards: G121811674, G1484969121, G1713883116, G2249638911, G29316538, Evaluation of the use of analogs of crotamine for diagnosis or therapy, G3309114178, G4656172147, G4710293253, G518087932, G5332324525, Validation of crotamine as a biomarker and evaluation of its potential use in the therapy of human diseases, G6845365225, G691262584, G7349477360
OpenAlex ID: W2947186623
